Qi He

600 Yishan Road
Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1

Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 02, 2026

Deficiency of Setd2 in mesenchymal stem cells facilitates the progression of myelodysplastic syndrome to leukemia.

Deficiency of Setd2 in mesenchymal stem cells facilitates the progression of myelodysplastic syndrome to leukemia.

Journal: Molecular medicine (Cambridge, Mass.)

Published: July 16, 2025

A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma.

A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma.

Journal: EJNMMI research

Published: June 20, 2025

Characteristics and prognostic implications of TP53 mutations in Chinese patients with myelodysplastic syndromes.

Characteristics and prognostic implications of TP53 mutations in Chinese patients with myelodysplastic syndromes.

Journal: British journal of haematology

Published: May 26, 2025

Prognostic impact of somatic mutations and additional chromosomal abnormalities in patients with myelodysplastic syndromes and chromosome 20q deletion.

Prognostic impact of somatic mutations and additional chromosomal abnormalities in patients with myelodysplastic syndromes and chromosome 20q deletion.

Journal: Clinical and experimental medicine

Published: January 19, 2025

Validation and improvement of the molecular international prognostic scoring system in Chinese patients with myelodysplastic syndromes.

Validation and improvement of the molecular international prognostic scoring system in Chinese patients with myelodysplastic syndromes.

Journal: Annals of hematology

Published: October 07, 2024

Significance of Mutation Spots and Concurrent Gene Mutations on Prognosis and Clinical Outcomes in Myelodysplastic Syndromes With SF3B1 Mutation.

Significance of Mutation Spots and Concurrent Gene Mutations on Prognosis and Clinical Outcomes in Myelodysplastic Syndromes With SF3B1 Mutation.

Journal: Cancer medicine

Published: August 28, 2024

Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype.

Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype.

Journal: Annals of hematology

Published: August 13, 2024

Eltrombopag restores proliferative capacity and adipose-osteogenic balance of mesenchymal stromal cells in low-risk myelodysplastic syndromes.

Eltrombopag restores proliferative capacity and adipose-osteogenic balance of mesenchymal stromal cells in low-risk myelodysplastic syndromes.

Journal: European journal of pharmacology

Published: June 24, 2024

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

Journal: Science advances

Published: November 29, 2023

The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus.

The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus.

Journal: Journal of cancer research and clinical oncology

Published: July 13, 2023

DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes.

DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes.

Journal: iScience

Published: February 04, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026